Cargando…

Biomarker candidates for cardiovascular disease and bone metabolism disorders in chronic kidney disease: a systems biology perspective

Patients with chronic kidney disease (CKD) show a panel of partially de-regulated serum markers indicative for bone metabolism disorders and cardiovascular diseases (CVDs). This review provides an overview of currently reported biomarker candidates at the interface of kidney disease, bone metabolism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perco, Paul, Wilflingseder, Julia, Bernthaler, Andreas, Wiesinger, Martin, Rudnicki, Michael, Wimmer, Barbara, Mayer, Bernd, Oberbauer, Rainer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2008
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865659/ https://www.ncbi.nlm.nih.gov/pubmed/18266955 http://dx.doi.org/10.1111/j.1582-4934.2008.00280.x

Ejemplares similares

Biocompatibility of peritoneal dialysis solutions determined by genomics of human leucocytes: a cross-over study
por: Wilflingseder, Julia, et al.
Publicado: (2009)

Integrative Bioinformatics Analysis of Proteins Associated with the Cardiorenal Syndrome
por: Mühlberger, Irmgard, et al.
Publicado: (2010)

From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of action
por: Heinzel, Andreas, et al.
Publicado: (2014)

Molecular Pathogenesis of Post-Transplant Acute Kidney Injury: Assessment of Whole-Genome mRNA and MiRNA Profiles
por: Wilflingseder, Julia, et al.
Publicado: (2014)

Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease
por: Leierer, Johannes, et al.
Publicado: (2021)

A 3-biomarker-panel predicts renal outcome in patients with proteinuric renal diseases
por: Neuwirt, Hannes, et al.
Publicado: (2014)

Increased Renal Versican Expression Is Associated with Progression of Chronic Kidney Disease
por: Rudnicki, Michael, et al.
Publicado: (2012)

Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis
por: Denicolò, Sara, et al.
Publicado: (2022)

Linking the ovarian cancer transcriptome and immunome
por: Rapberger, Ronald, et al.
Publicado: (2008)

Candidate composite biomarker to inform drug treatments for diabetic kidney disease
por: Jones, Roger D., et al.
Publicado: (2023)

Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis
por: Aschauer, Constantin, et al.
Publicado: (2017)

Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease
por: Khurana, Rimpi, et al.
Publicado: (2017)

Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease
por: Niizuma, Shinichiro, et al.
Publicado: (2017)

Multimarker Panels in Diabetic Kidney Disease: The Way to Improved Clinical Trial Design and Clinical Practice?
por: Perco, Paul, et al.
Publicado: (2018)

Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
por: Heerspink, Hiddo J. L., et al.
Publicado: (2019)

Lessons from effect of etelcalcetide on left ventricular hypertrophy in patients with end-stage kidney disease
por: Dörr, Katharina, et al.
Publicado: (2022)

Computational Drug Screening Identifies Compounds Targeting Renal Age-associated Molecular Profiles
por: Koppelstaetter, Christian, et al.
Publicado: (2019)

Analysis and prediction of protective continuous B-cell epitopes on pathogen proteins
por: Sollner, Johannes, et al.
Publicado: (2008)

Sirolimus Induced Phosphaturia is Not Caused by Inhibition of Renal Apical Sodium Phosphate Cotransporters
por: Haller, Maria, et al.
Publicado: (2012)

Intra-individual variability of eGFR trajectories in early diabetic kidney disease and lack of performance of prognostic biomarkers
por: Kerschbaum, Julia, et al.
Publicado: (2020)

Antibody Response to mRNA Vaccines against SARS-CoV-2 with Chronic Kidney Disease, Hemodialysis, and after Kidney Transplantation
por: Buchwinkler, Lukas, et al.
Publicado: (2021)

Introducing Serine as Cardiovascular Disease Biomarker Candidate via Pathway Analysis
por: Rezaei Tavirani, Mostafa, et al.
Publicado: (2020)

Race, Biomarkers, and Cardiovascular Disease in Patients With Chronic Kidney Disease
por: Nicholas, Susanne B., et al.
Publicado: (2022)

An Interaction Network Predicted from Public Data as a Discovery Tool: Application to the Hsp90 Molecular Chaperone Machine
por: Echeverría, Pablo C., et al.
Publicado: (2011)

Regression methods for investigating risk factors of chronic kidney disease outcomes: the state of the art
por: Boucquemont, Julie, et al.
Publicado: (2014)

Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation
por: Chadban, Steven J., et al.
Publicado: (2020)

COVID-19: implications for immunosuppression in kidney disease and transplantation
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Circulating miRNAs as biomarkers of kidney disease
por: Hüttenhofer, Alexander, et al.
Publicado: (2017)

The effect of steroid pretreatment of deceased organ donors on liver allograft function: A blinded randomized placebo-controlled trial
por: Amatschek, Stefan, et al.
Publicado: (2012)

Characterization of protein-interaction networks in tumors
por: Platzer, Alexander, et al.
Publicado: (2007)

Cathepsin S as an early biomarker for cardiovascular disease in chronic kidney disease patients
por: Sonkar, Satyendra Kumar, et al.
Publicado: (2022)

Predictive Biomarkers in Nephrology Around the Corner
por: Perco, Paul, et al.
Publicado: (2019)

Health-related quality of life outcomes after kidney transplantation
por: Fiebiger, Wolfgang, et al.
Publicado: (2004)

Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective
por: Bozic, Josko, et al.
Publicado: (2021)

Serum VEGF-C levels as a candidate biomarker of hypervolemia in chronic kidney disease
por: Sahutoglu, Tuncay, et al.
Publicado: (2017)

Strategies to increase the donor pool and access to kidney transplantation: an international perspective
por: Maggiore, Umberto, et al.
Publicado: (2015)

Different roles of protein biomarkers predicting eGFR trajectories in people with chronic kidney disease and diabetes mellitus: a nationwide retrospective cohort study
por: Kammer, Michael, et al.
Publicado: (2023)

The Role of Novel Biomarkers of Cardiovascular Disease in Chronic Kidney Disease: Focus on Adiponectin and Leptin
por: Kaisar, Omar M, et al.
Publicado: (2008)

Biological Networks for Cancer Candidate Biomarkers Discovery
por: Yan, Wenying, et al.
Publicado: (2016)

A Panel of Novel Biomarkers Representing Different Disease Pathways Improves Prediction of Renal Function Decline in Type 2 Diabetes
por: Pena, Michelle J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pmtpm5qe8n4c0ubfjqdc329d3v